Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Galmarini

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Transplantation Proceedings|October 1, 1996
Oral administration of FK 506 in a swine model of liver-small bowel allotransplantationP Reggiani, S Gatti, G Rossi, et al.
Plos One|May 11, 2011
Irvalec inserts into the plasma membrane causing rapid loss of integrity and necrotic cell death in tumor cellsJosé M Molina-Guijarro, Álvaro Macías, Carolina García, et al.
Blood|September 30, 2004
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populationsJohn R Mackey, Carlos M Galmarini, Kathryn A Graham, et al.
Oncogene|November 12, 2013
Mode of action of trabectedin in myxoid liposarcomasS Di Giandomenico, R Frapolli, E Bello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancerA Poveda, J M Del Campo, I Ray-Coquard, et al.
Haematologica|February 19, 2011
Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage responseEnrique Colado, Teresa Paíno, Patricia Maiso, et al.
British Journal of Cancer|January 11, 2017
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasmsMichela Romano, Matteo Giovanni Della Porta, Anna Gallì, et al.
Cancer Cell|February 16, 2013
Role of macrophage targeting in the antitumor activity of trabectedinGiovanni Germano, Roberta Frapolli, Cristina Belgiovine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2018
Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment SubstudyCristina Cruz, Alba Llop-Guevara, Judy E Garber, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Transplantation Proceedings|October 1, 1996
Oral administration of FK 506 in a swine model of liver-small bowel allotransplantationP Reggiani, S Gatti, G Rossi, et al.
Plos One|May 11, 2011
Irvalec inserts into the plasma membrane causing rapid loss of integrity and necrotic cell death in tumor cellsJosé M Molina-Guijarro, Álvaro Macías, Carolina García, et al.
Blood|September 30, 2004
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populationsJohn R Mackey, Carlos M Galmarini, Kathryn A Graham, et al.
Oncogene|November 12, 2013
Mode of action of trabectedin in myxoid liposarcomasS Di Giandomenico, R Frapolli, E Bello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancerA Poveda, J M Del Campo, I Ray-Coquard, et al.
Haematologica|February 19, 2011
Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage responseEnrique Colado, Teresa Paíno, Patricia Maiso, et al.
British Journal of Cancer|January 11, 2017
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasmsMichela Romano, Matteo Giovanni Della Porta, Anna Gallì, et al.
Cancer Cell|February 16, 2013
Role of macrophage targeting in the antitumor activity of trabectedinGiovanni Germano, Roberta Frapolli, Cristina Belgiovine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2018
Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment SubstudyCristina Cruz, Alba Llop-Guevara, Judy E Garber, et al.
Pageof 13